RSS  JOBS   SITE MAP 
 HOME 
PHARMA
BIO TECHNOLOGY
MEDICAL TECHNOLOGY
 RESOURCE CENTER 
 SUBSCRIBE 
 SUBSCRIBE ASIA DIGEST 
  Friday, September 3, 2010 SEARCH     
 
BIO AUSTRALIA
BIO CHINA
BIO INDIA
BIO INDONESIA
BIO JAPAN
BIO KOREA
BIO MALAYSIA
BIO NEW ZEALAND
BIO PHILIPPINES
BIO SINGAPORE
BIO TAIWAN
BIO THAILAND
 
POLICY DEVELOPMENTS
FDA warns consumers to avoid TimeOut capsules
The US FDA has warned consumers not to take TimeOut capsules because it contains an active drug ingredient that can dangerously lower blood pressure. The product is marketed as a dietary supplement for sexual enhancement
Pfizer's Prevenar 13 gets WHO prequalification
The WHO has granted prequalification to Prevenar 13 for active immunization of infants and children from six weeks through five years of age against invasive disease, pneumonia and otitis media.
TODAY'S NEWS
  Scientists discover protein that fuels Alzheimer's disease
  Agensys initiates phase I of renal cancer drug
  Pfizer to acquire drug developer FoldRx
  Varian establishes radiotherapy training center in India
  Yongye enters into $59 mn revolving credit facilities
  Ono licenses Concordia's cancer drug in Japan
 
Advertisement
 
Digital Mag

Issue: July, 2010
Current Issue
View / Download
Top Story
Are biofuels poised for a leap?
 
 
 
Get the latest news on life sciences in your mail box
Name
E-Mail Id
 
 
Advertisement



















 

POLICIES
 
US FDA launches performance management system
The US FDA launched an innovative performance management system designed to advance the US President Barack Obama's commitment to transparency, public participation, and collaboration in the work of government
 
Takeda gets $42 mn subsidy to develop pandemic flu vax
Takeda has been granted a government subsidy of $42 million for the development and production of pandemic influenza vaccines
 
FDA extends review of Eisai's cancer drug
FDA expects to complete priority review of the eribulin mesylate NDA for metastatic breast cancer by December 30, 2010
 
Novartis receives FDA approval of Tekamlo to treat high BP
The US FDA approved Tekamlo tablets, a single-pill for the treatment of high blood pressure combining the only approved direct renin inhibitor, Tekturna (aliskiren), with the widely used calcium channel blocker amlodipine.
 
Anti-clotting drug Brilinta needs no genetic testing: Study
AstraZeneca, a global biopharmaceutical company, said clinical research showed that its experimental anti-clotting drug Brilinta requires no genetic testing to check if it will work.
 
Sanofi says FDA is considering expanded vaccine use
Sanofi Pasteur, the vaccines division of French drugmaker Sanofi-Aventis, announced that the USFDA has accepted its application to extend the age group that can receive Menactra, a vaccine that can prevent meningococcal disease.
 
Olive polyphenols get Aussie patent for UV protection
CreAgri has received a Australian Patent covering the protective effects provided by Hydroxytyrosol against skin damage caused by UV exposure
 
FDA warns consumers to avoid TimeOut capsules
The US FDA has warned consumers not to take TimeOut capsules because it contains an active drug ingredient that can dangerously lower blood pressure. The product is marketed as a dietary supplement for sexual enhancement
 
Pfizer's Prevenar 13 gets WHO prequalification
The WHO has granted prequalification to Prevenar 13 for active immunization of infants and children from six weeks through five years of age against invasive disease, pneumonia and otitis media.
 
Hospira gets approval for new indication for 'Precedex IV 200ug'
Hospira, a specialty pharmaceutical and medication delivery company in Japan, has has received approval for the long-term use of the sedative "Precedex IV 200ug"
More
 
Advertisement





 
   
 
Google
BioSpectrumAsia.com BioSpectrumIndia.com Web

About BioSpectrum | How to Advertise | Jobs at BioSpectrum | Jobs at CyberMedia | Contact Us | Privacy Statement



CyberMedia Network Websites


[Voice&Data]  [PCQuest]  [CIOL]  [Dataquest]  [Living Digital]  [IDC India]
[DQ Channels]  [The DQweek]  [DARE]  
[CyberMedia Events] [CyberMedia Digital]  [Cyber Astro]  [CyberMedia India]  [Global Services]  [BioSpectrum]

 
Copyrights are reserved for BioSpectrum ; Designed by : Altered Black